v3.25.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities    
Net income $ 2,132 $ 681
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Inventories allowances 32 6
Allowance for credit losses 0 0
Deferred tax benefit (1,544) 0
Depreciation and amortization 427 407
Loss on investments 0 91
Changes in operating assets and liabilities:    
Trade accounts receivable (2,822) (3,565)
Inventories 1,371 1,403
Prepaid expenses and other current assets 402 (100)
Capitalized product development cost (440) (147)
Other assets (1) 24
ROU assets and lease liabilities (19) (15)
Accounts payable 784 (755)
Long-term uncertain tax position liability 1,419 0
Accrued compensation and related taxes (534) 275
Accrued warranty expense (16) 52
Deferred revenue (302) 673
Accrued other expenses and other current liabilities 818 8
Net cash provided by (used in) operating activities 2,100 (786)
Investing activities    
Purchases of property, plant, and equipment (268) (214)
Net cash used in investing activities (268) (214)
Financing activities    
Proceeds from common stock issuance 13 0
Proceeds from the credit facility and notes payable 0 15,029
Repayment of the credit facility and notes payable 0 (14,189)
Net cash provided by financing activities 13 840
Net change in cash and cash equivalents 1,845 (160)
Cash and cash equivalents, beginning of period 7,075 3,456
Cash and cash equivalents, end of period 8,920 3,296
Supplemental disclosure    
Cash paid for interest 0 202
Non-cash financing activity    
Common stock issued under restricted stock units 138 47
Cashless exercise of stock options and related conversion of net shares to stockholders' equity 3 0
Share-Based Payment Arrangement, Option [Member]    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Share-based compensation expense-stock options 118 55
Restricted Stock Units (RSUs) [Member]    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Share-based compensation expense-stock options $ 275 $ 121